39 related articles for article (PubMed ID: 27155004)
1. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.
Shen X; Ye Y; Qi J; Shi W; Wu X; Ni H; Cong H; Ju S
Clin Chem Lab Med; 2017 May; 55(5):748-754. PubMed ID: 27155004
[TBL] [Abstract][Full Text] [Related]
2. A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.
Papanota AM; Karousi P; Kontos CK; Artemaki PI; Liacos CI; Papadimitriou MA; Bagratuni T; Eleutherakis-Papaiakovou E; Malandrakis P; Ntanasis-Stathopoulos I; Gavriatopoulou M; Kastritis E; Avgeris M; Dimopoulos MA; Scorilas A; Terpos E
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884950
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
Bao Y; Wei M; Ji X
J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
[TBL] [Abstract][Full Text] [Related]
4. Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma.
Soliman AM; Lin TS; Mahakkanukrauh P; Das S
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066062
[TBL] [Abstract][Full Text] [Related]
5. Do Alarmins Have a Role in Multiple Myeloma?
Gedük A; Polat MG; Terzi Demirsoy E; Öztaş B; Eryılmaz BH; Yenihayat EM; Albayrak H; Erol HA; Mehtap Ö; Tarkun P; Hacıhanefioğlu A
Turk J Haematol; 2024 May; 41(2):83-90. PubMed ID: 38426298
[TBL] [Abstract][Full Text] [Related]
6. Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.
Levin N; Spencer A; Harrison SJ; Chauhan D; Burrows FJ; Anderson KC; Reich SD; Richardson PG; Trikha M
Br J Haematol; 2016 Sep; 174(5):711-20. PubMed ID: 27161872
[TBL] [Abstract][Full Text] [Related]
7. Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum.
Shen X; Zhang Y; Wu X; Guo Y; Shi W; Qi J; Cong H; Wang X; Wu X; Ju S
Cancer Biomark; 2017; 18(3):257-263. PubMed ID: 28085010
[TBL] [Abstract][Full Text] [Related]
8. Identification specific miRNA in t(4;14) multiple myeloma based on miRNA-mRNA expressing profile correlation analysis.
Liu H; Wang G; Huang Y; Zhao C; Chen J; Wang X
J Cell Biochem; 2019 Feb; 120(2):2454-2468. PubMed ID: 30230597
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 and BRCA2 expression patterns and prognostic significance in digestive system cancers.
Wang GH; Zhao CM; Huang Y; Wang W; Zhang S; Wang X
Hum Pathol; 2018 Jan; 71():135-144. PubMed ID: 29126833
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma.
Shen X; Xue Y; Cong H; Wang X; Ju S
Ann Clin Biochem; 2018 Jul; 55(4):478-484. PubMed ID: 29065698
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of miR-335 induces migration by targeting insulin-like growth factor-1 receptor in multiple myeloma.
Qi J; Shi LY; Wu Y; Shen XJ; Yuan J; Jin CJ; Cong H; Ju SQ
Leuk Lymphoma; 2019 Dec; 60(13):3188-3198. PubMed ID: 31190579
[TBL] [Abstract][Full Text] [Related]
13. Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma.
Dubaj M; Bigosiński K; Dembowska A; Mlak R; Szudy-Szczyrek A; Małecka-Massalska T; Homa-Mlak I
Cancers (Basel); 2024 Mar; 16(5):. PubMed ID: 38473390
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA EIF4G3 suppresses gastric cancer progression through inhibition of β-catenin by promoting δ-catenin ubiquitin degradation and upregulating SIK1.
Zang X; Jiang J; Gu J; Chen Y; Wang M; Zhang Y; Fu M; Shi H; Cai H; Qian H; Xu W; Zhang X
Mol Cancer; 2022 Jul; 21(1):141. PubMed ID: 35780119
[TBL] [Abstract][Full Text] [Related]
15. Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.
Xiang Y; Zhang L; Xiang P; Zhang J
Front Oncol; 2021; 11():698197. PubMed ID: 34307166
[TBL] [Abstract][Full Text] [Related]
16. Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis.
Soliman AM; Das S; Teoh SL
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299097
[TBL] [Abstract][Full Text] [Related]
17. Alterations in MicroRNA gene expression profile in liver transplant patients with hepatocellular carcinoma.
Afshari A; Yaghobi R; Karimi MH; Mowla J
BMC Gastroenterol; 2021 Jun; 21(1):262. PubMed ID: 34118888
[TBL] [Abstract][Full Text] [Related]
18. microR-4449 Promotes Colorectal Cancer Cell Proliferation via Regulation of SOCS3 and Activation of STAT3 Signaling.
Yan Z; Hong S; Song Y; Bi M
Cancer Manag Res; 2021; 13():3029-3039. PubMed ID: 33854373
[TBL] [Abstract][Full Text] [Related]
19. The Neat Dance of COVID-19: NEAT1, DANCR, and Co-Modulated Cholinergic RNAs Link to Inflammation.
Meydan C; Madrer N; Soreq H
Front Immunol; 2020; 11():590870. PubMed ID: 33163005
[TBL] [Abstract][Full Text] [Related]
20. Potential diagnostic value of circulating miRNA for multiple myeloma: A meta-analysis.
Gao SS; Wang YJ; Zhang GX; Zhang WT
J Bone Oncol; 2020 Dec; 25():100327. PubMed ID: 33145153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
